[Progress in the treatment of nephrotic syndrome].
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D006801:Humans; D007116:Immunization, Passive; D009404:Nephrotic Syndrome / Q000628:therapy*; D010951:Plasma Exchange; D010956:Plasmapheresis; D011239:Prednisolone / Q000627:therapeutic use; D005719:gamma-Globulins / Q000008:administration & dosage
D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D005719:gamma-Globulins; D011239:Prednisolone